[HTML][HTML] Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development

AV Samarelli, V Masciale, B Aramini, GP Coló… - International journal of …, 2021 - mdpi.com
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung
disease (ILD) of unknown aetiology, with a median survival of 2–4 years from the time of …

Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development.

A Samarelli, V Masciale, B Aramini, G Coló… - INTERNATIONAL …, 2021 - cris.unibo.it
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung
disease (ILD) of unknown aetiology, with a median survival of 2–4 years from the time of …

[PDF][PDF] Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development

AV Samarelli, V Masciale, B Aramini, GP Coló… - Int. J. Mol. Sci, 2021 - academia.edu
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung
disease (ILD) of unknown aetiology, with a median survival of 2–4 years from the time of …

Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development

AV Samarelli, V Masciale, B Aramini, GP Colo… - 2021 - notablesdelaciencia.conicet.gov.ar
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung
disease (ILD) of unknown aetiology, with a median survival of 2–4 years from the time of …

Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development

AV Samarelli, V Masciale, B Aramini, GP Coló… - 2021 - agris.fao.org
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung
disease (ILD) of unknown aetiology, with a median survival of 2–4 years from the time of …

Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development.

AV Samarelli, V Masciale, B Aramini… - … Journal of Molecular …, 2021 - europepmc.org
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung
disease (ILD) of unknown aetiology, with a median survival of 2–4 years from the time of …

[PDF][PDF] Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development

AV Samarelli, V Masciale, B Aramini, GP Coló… - Int. J. Mol. Sci, 2021 - core.ac.uk
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung
disease (ILD) of unknown aetiology, with a median survival of 2–4 years from the time of …

Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development

AV Samarelli, V Masciale, B Aramini, GP Colo… - 2021 - datosdeinvestigacion.conicet.gov.ar
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung
disease (ILD) of unknown aetiology, with a median survival of 2–4 years from the time of …

[PDF][PDF] Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development

AV Samarelli, V Masciale, B Aramini, GP Colo… - 2021 - ri.conicet.gov.ar
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung
disease (ILD) of unknown aetiology, with a median survival of 2–4 years from the time of …

[PDF][PDF] Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development

AV Samarelli, V Masciale, B Aramini… - Int. J. Mol …, 2021 - pdfs.semanticscholar.org
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung
disease (ILD) of unknown aetiology, with a median survival of 2–4 years from the time of …